AOCI at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Integra LifeSciences's AOCI?
- Integra LifeSciences (IART) reported AOCI of -$30.94M in Q1 2026.
- How has Integra LifeSciences's AOCI changed year-over-year?
- Integra LifeSciences's AOCI decreased by 28.3% year-over-year, from -$24.11M to -$30.94M.
- What is the long-term trend for Integra LifeSciences's AOCI?
- Over 5 years (2020 to 2025), Integra LifeSciences's AOCI has grown at a -16.5% compound annual growth rate (CAGR), from -$74.06M to -$30.08M.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.